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Multivariate regression analysis showing independent predictors of saphenous
vein graft occlusion.
Odds ratio 95% conﬁdence interval P value
Time after CABG surgery 0.93 0.87-0.99 0.04
MPV 0.26 0.17-0.39 <0.001
HDL cholesterol 1.04 1.01-1.08 0.012
Fibrinogen 0.27 0.16-0.48 <0.001
CABG, coronary artery bypass graft; HDL, high-density lipoprotein; MPV, mean platelet volume.
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ical, hematologic, and angiographic datas were analyzed.
Results: Patients were divided into 3 tertiles according to the RDW values (12.9 
0.4, 14.2  0.4 and 16.3  1.5 respectively). Stent thrombosis developed in 47
(40.9%) patients in the lowest tertile, 39 (37.9%) patients in the middle tertile and 60
(58.3%) patients in the highest tertile (p¼0.006). Female gender ratio was signiﬁcantly
high in the highest tertile (13 (11.3%), 8 (7.8%), 24 (23.3%), p¼0.003, respectively).
The RDW (odds ratio:1.397, 95% CI: 1.177- 1.657, p<0.001), platelet count (odds
ratio:1.008, 95% CI: 1.004-1.012, p<0.001) remained independent predictors of stent
thrombosis after multivariate logistic regression analysis. Receiver–operating char-
acteristic (ROC) curve analysis demonstrated a cut off value 13.9 for the RDW,
predicted the development of stent thrombosis with a sensitivity of 57% and speci-
ﬁcity of 52% (Area under the ROC curve: 0.59, 95% CI: 0.53 to 0.65, p¼0.007).
Conclusıon: High RDW values were found to be independently associated with the
development of stent thrombosis in patients with ST-elevation MI.
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Background: We aimed to investigate the pharmacoeconomic efﬁcacy of ivabradine
and nebivolol in treatment of stable angina pectoris patients with left ventricular
dysfunction.
Methods: This prospective study included 34 patients with a left ventricular ejection
fraction (LVEF) 40% that were followed-up by the cardiology department; 15 (44%)
patients were male, 19 (56%) were female, and mean age was 615.1 years. Patients
treated with nebivolol (17 patients, 50%) formed nebivolol group, patients who could
not tolerate nebivolol and treated with ivabradine (17 patients, 50%) formed ivabra-
dine group. The parameters recorded included heart rates, LVEF, hospitalization rates,
quality of life (QoL) based on the Seattle Angina Questionnaire (SAQ) scores, the
Duke Treadmill Score (DTS). Pharmacoeconomic analysis was performed by using
Cost Minimization Analysis (CMA), and Cost Effectiveness Analysis (CEA).
Results: After 6 months’ treatment ivabradine (mean dose 122.5 mg daily) reduced
heart rate by (1028.9) to (663.2) beat per minute (bpm), (p<0.05), and nebivolol
(mean dose 40.8 mg/day) reduced heart rate by (1059.1) to (674.3) bpm
(p<0.05). LVEF for the nebivolol group improved by (386.5) to (413.2), (p>0.05)
and for the ivabradine group (375.4) to (412.3), (p>0.05). The mean MET value
in the nebivolol group increased from (3.71.2) to (5.51.6), (p>0.05), versus from
(3.61.5) to (5.51.4), (p>0.05) in the ivabradine group. After 6 months’ treatment
CMA results showed a difference in the total cost of treatment was $ 5288.70 in favor
of nebivolol.
Conclusıons: The ﬁndings of this study suggest that nebivolol is more cost-effective
than ivabradine in the treatment of stable angina pectoris in patients with left
ventricular dysfunction.
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Background: Fibrinogen is related to pathogenesis of atherosclerosis. The inﬂam-
matory process in atherosclerosis may cause an increase in plasma ﬁbrinogen level.
Therefore, in this study we purposed to investigate whether plasma ﬁbrinogen is
associated with the patency of saphenous vein graft in patients at least 1 year after
coronary artery bypass graft (CABG) surgery.
Methods: Patients who had undergone CABG surgery at least 1 year previously with
at least one saphenous vein graft were included in the study. Patients were directed to
cardiac catheterization for stable anginal symptoms or positive stress test results.
Before coronary angiography, all patients had routine blood tests including plasma
ﬁbrinogen levels.
Results: Saphenous vein grafts were found to be patent in 199 patients and occluded
in 132 patients. Plasma ﬁbrinogen levels were signiﬁcantly different between the two
groups (2.850.49 g/L vs. 3.620.82 g/L, p<0.001, respectively). Although time
after CABG operation differs signiﬁcantly between the two groups (p¼0.004),
multiple logistic regression analysis showed that plasma ﬁbrinogen levels were found
to be signiﬁcantly associated with the patency of vein graft (OR¼0.27, 95% CI 0.16-
0.48, p<0.001) (Table). In addition, a plasma ﬁbrinogen value >3.45 g/L was
determined to predict saphenous graft vein disease with a sensitivity of 57% and
a speciﬁcity of 91% (AUC (area under the curve) ¼0.784) (Figure).
Conclusıon: Our results demonstrated that plasma ﬁbrinogen levels were higher in
patients with an occluded saphenous vein graft. To prove this relationship between
plasma ﬁbrinogen values and saphenous vein graft patency, further investigations are
needed.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-279
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Aım: Mediterranean diet (MD) is considered a model for healthy eating. However,
prospective evidence in Turkey evaluating the relationship between MD and cardio-
vascular events is scarce. We surveyed the adherence of Turkish population to MD
and its association with cardiovascular disease (CVD).
Methods-Results: Followed-up 900 participants (52 percent women) initially free of
cardiovascular disease (CVD) during 5.1 years. The general dietary habits of study
population were detected with a food frequency quetionnaire. Data obtained from that
questionnaire were tested with Mediterranean diet score in order to ﬁnd out the
relevance to Mediterranean diet. A MD score (scale 0–8) was computed reﬂecting
high ratio of monounsaturated to saturated fat; high intake of alcohol, legumes,
cereals, vegetables, and fruits; low intakes of meat and it's products, milk and dairy
products. Scoring <5 was deﬁned as Low-MD consuming, while 5+ as High-MD
consuming. We observed 25 incident cases of CVD. Consumption of High-MD was
21% in men and 19% in women. The risk for myocardial infarction, coronary bypass,
angioplasty, and any cardiovascular disease in men increased by 1.3 (p¼0.02), 1.4
(p¼0.03), 1.5 (p¼0.01), and 1.3 (p¼0.02), respectively, for each MD score decrease.
In women, the risk for myocardial infarction and angioplasty increased by 1.3
(p¼0.02) and 1.5 (p¼0.01), respectively, for each MD score decrease. The risk for
coronary bypass, and any cardiovascular disease in women, crude odds ratios ranged
from 1.1 to 1.3 but were not statistically signiﬁcant.
Conclusıons: The current rate of MD in Turkey is fairly low. There is an inverse
association between adherence to MD and the incidence of fatal and non-fatal CVD in
initially healthy adults.ERS C193
